Live Breaking News & Updates on Prnewswire Biotheryx Inc

Stay updated with breaking news from Prnewswire biotheryx inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biotheryx to Present New Preclinical Data on Bifunctional Degraders for CDK4/6 and SOS1 at 2023 ASCO Annual Meeting

/PRNewswire/ Biotheryx, Inc., a biopharmaceutical company discovering and developing a portfolio of first-in-class protein degraders with a focus on. ....

United States , Kyle Begovich , Hannah Majeski , Philippe Drouet , Prnewswire Biotheryx Inc , American Society Of Clinical Oncology , Clinical Oncology , Annual Meeting , Chief Executive Officer , Meeting Presentation Details , Principal Scientist , Breast Cancer , Senior Scientist , Developmental Therapeutics , Molecularly Targeted Agents , Tumor Biology ,

Biotheryx Announces Research Collaboration and License Agreement with Incyte for Discovery of Targeted Protein Degraders for Novel Oncology Targets

/PRNewswire/ Biotheryx, Inc., a biopharmaceutical company discovering and developing a portfolio of first-in-class protein degraders with a focus on. ....

Dashyant Dhanak , Philippe Drouet , Research Collaboration , Prnewswire Biotheryx Inc , Chief Executive Officer , Executive Vice President , Chief Scientific Officer ,

Biotheryx to Participate in Wells Fargo 2023 Targeted Protein Degradation Virtual Summit

/PRNewswire/ Biotheryx, Inc., a clinical stage company discovering and developing a portfolio of innovative small molecule targeted protein degraders (TPDs). ....

Aparajita Hoskote Chourasia , Leah Fung , Prnewswire Biotheryx Inc , Panel Discussion , Wells Fargo , Protein Degradation Virtual Summit , Overcoming Resistance , Targeted Protein , Vice President , Targeted Protein Degradation Make Sense , Chief Scientific ,

Biotheryx Announces Appointment of Tracy Lawhon as Chief Development Officer

/PRNewswire/ Biotheryx, Inc., a clinical stage company discovering and developing a portfolio of innovative small molecule targeted protein degraders (TPDs). ....

Philippe Drouet , Tracy Lawhon , Indiana University , Adastra Pharmaceuticals Inc , Indiana University School Of Law , Plough Research Institute , Clinical Operations At Valo Health Inc , Cabrellis Pharmaceuticals , Prnewswire Biotheryx Inc , Strategic Development , Chief Development Officer , Chief Executive Officer , Vice President , Clinical Operations , Valo Health Inc , Adastra Pharmaceuticals , Chief Operating Officer , Schering Plough Research , Indiana University School ,

Biotheryx to Present Preclinical Data for Its Dual Protein Degrader BTX-1188 at the 2022 American Society of Clinical Oncology Annual Meeting

/PRNewswire/ Biotheryx, Inc., a clinical stage company discovering and developing a portfolio of innovative small molecule targeted protein degraders (TPDs). ....

United States , Ikaros Aiolos , Aparajita Hoskote Chourasia , Philippe Drouet , Leah Fung , American Society Of Clinical Oncology , Biotheryx Inc , Drug Administration , Prnewswire Biotheryx Inc , Development For The Treatment Of Hematologic , Beneficial Immunomodulatory Properties , Durable Dual Degradation , Vitro Along , Beneficial Immunomodulatory , Support Ongoing Phase , Solid Tumor , Clinical Oncology , Annual Meeting , Chief Scientific Officer , Chief Executive Officer , Hematologic Malignancies , Myelodysplastic Syndromes ,